(6S)-2-nitro-6-{[4-(trifluoromethoxy)phenyl](2H2)methoxy}(5,5-2H2)-5H,6H,7H-imidazo[2,1-b][1,3]oxazine

• ChemBase编号: 176151
• 分子式: C14H12F3N3O5
• 平均质量: 359.2573896
• 单一同位素质量: 359.07290516
• SMILES: c12n(C[C@@H](CO1)OCc1ccc(cc1)OC(F)(F)F)cc(n2)[N+](=O)[O-]
• Canonical SMILES: [O-][N+](=O)c1cn2c(n1)OC[C@H](C2)OCc1ccc(cc1)OC(F)(F)F
• InChI: InChI=1S/C14H12F3N3O5/c15-14(16,17)25-10-3-1-9(2-4-10)7-23-11-5-19-6-12(20(21)22)18-13(19)24-8-11/h1-4,6,11H,5,7-8H2/t11-/m0/s1
• InChIKey: ZLHZLMOSPGACSZ-NSHDSACASA-N

名称和登记号

名称

• IUPAC标准名: (6S)-2-nitro-6-{[4-(trifluoromethoxy)phenyl](^2H₂)methoxy}(5,5-^2H₂)-5H,6H,7H-imidazo[2,1-b][1,3]oxazine
• IUPAC传统名: (6S)-2-nitro-6-{[4-(trifluoromethoxy)phenyl](^2H₂)methoxy}(5,5-^2H₂)-6H,7H-imidazo[2,1-b][1,3]oxazine
• 别名: (6S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine-d4; (S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine-d4; PA 824-d4; (S)-PA 824-d4

登记号

• PubChem SID: 164232061
• PubChem CID: 71751425

理论计算性质

• 质子受体: 6
• 质子供体: 0
• LogD (pH = 5.5): 4.1363235
• LogD (pH = 7.4): 4.1363235
• Log P: 4.1363235
• 摩尔折射率: 73.9118 cm^3
• 极化性: 28.832218 Å^3
• 极化表面积: 91.33 Å^2
• 可自由旋转的化学键: 6
• 里宾斯基五规则: true

详细说明

Toronto Research Chemicals - P122502

A labelled novel anti-tuberculosis drug.

参考文献

• Diacon, A.H. et al.: Antimicrob. Anents Chemother., 54, 3402 (2010)
• Dogra, M. et al.: Br. J. Pharmacol., 162, 226 (2010)
• Ginsberg, A.M. et al.: Antimicrob. Agents Chemother., 53, 3720 (2010)